Virtu KCG Holdings’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$152K Sell
22,433
-56,936
-72% -$386K ﹤0.01% 2277
2017
Q1
$749K Buy
79,369
+30,533
+63% +$288K 0.02% 947
2016
Q4
$422K Buy
48,836
+12,991
+36% +$112K 0.01% 1677
2016
Q3
$227K Sell
35,845
-7,867
-18% -$49.8K 0.01% 2234
2016
Q2
$184K Buy
43,712
+18,142
+71% +$76.4K ﹤0.01% 2339
2016
Q1
$111K Buy
25,570
+293
+1% +$1.27K ﹤0.01% 2299
2015
Q4
$155K Sell
25,277
-8,750
-26% -$53.7K ﹤0.01% 2320
2015
Q3
$195K Sell
34,027
-12,725
-27% -$72.9K ﹤0.01% 2122
2015
Q2
$349K Buy
46,752
+32,270
+223% +$241K 0.01% 1498
2015
Q1
$87K Sell
14,482
-11,810
-45% -$70.9K ﹤0.01% 2185
2014
Q4
$199K Buy
26,292
+12,334
+88% +$93.4K ﹤0.01% 2042
2014
Q3
$72K Buy
+13,958
New +$72K ﹤0.01% 2363
2014
Q2
Sell
-12,578
Closed -$51K 3016
2014
Q1
$51K Buy
+12,578
New +$51K ﹤0.01% 2140
2013
Q4
Sell
-20,267
Closed -$102K 3112
2013
Q3
$102K Buy
+20,267
New +$102K ﹤0.01% 2274